SMO ClinPlus CO.,LTD. (SHE:301257)
China
· Delayed Price · Currency is CNY 57.14
+0.78 (1.38%)
Apr 28, 2026, 4:00 PM EDT
SMO ClinPlus CO.,LTD. Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 842.5 | 803.73 | 760.04 | 586.23 | 502.97 | Upgrade
|
| Other Revenue | - | - | 0 | 0 | - | Upgrade
|
| Revenue | 842.5 | 803.73 | 760.04 | 586.23 | 502.97 | Upgrade
|
| Revenue Growth (YoY) | 4.82% | 5.75% | 29.65% | 16.55% | 50.01% | Upgrade
|
| Cost of Revenue | 624.56 | 607.75 | 528.94 | 426.25 | 371.77 | Upgrade
|
| Gross Profit | 217.95 | 195.98 | 231.1 | 159.98 | 131.19 | Upgrade
|
| Selling, General & Admin | 54.25 | 52.37 | 50.28 | 49.86 | 33.74 | Upgrade
|
| Research & Development | 38.77 | 35.84 | 34.75 | 32.23 | 21.19 | Upgrade
|
| Other Operating Expenses | -9.42 | 5.29 | 5.18 | 2.99 | 2.94 | Upgrade
|
| Operating Expenses | 83.61 | 102.54 | 100.58 | 91.25 | 63.71 | Upgrade
|
| Operating Income | 134.34 | 93.44 | 130.52 | 68.73 | 67.49 | Upgrade
|
| Interest Expense | - | -0.44 | -0.32 | -0.18 | -0.27 | Upgrade
|
| Interest & Investment Income | 7.23 | 16.35 | 16.44 | 6.82 | 1.73 | Upgrade
|
| Other Non Operating Income (Expenses) | -5.7 | -0.77 | -0.48 | 0.19 | -0.52 | Upgrade
|
| EBT Excluding Unusual Items | 135.86 | 108.58 | 146.16 | 75.56 | 68.42 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.31 | 0.58 | 1.14 | 0.84 | -1.47 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.03 | -0.12 | 0.02 | 0.02 | -0.08 | Upgrade
|
| Asset Writedown | -8.32 | - | -0.01 | -0 | -0 | Upgrade
|
| Other Unusual Items | - | 12.54 | 13.72 | 4.41 | - | Upgrade
|
| Pretax Income | 127.88 | 121.58 | 161.03 | 80.84 | 66.88 | Upgrade
|
| Income Tax Expense | 18.24 | 15.15 | 26.3 | 8.43 | 9.11 | Upgrade
|
| Net Income | 109.64 | 106.43 | 134.73 | 72.41 | 57.77 | Upgrade
|
| Net Income to Common | 109.64 | 106.43 | 134.73 | 72.41 | 57.77 | Upgrade
|
| Net Income Growth | 3.02% | -21.00% | 86.06% | 25.35% | 63.58% | Upgrade
|
| Shares Outstanding (Basic) | 79 | 79 | 78 | 70 | 59 | Upgrade
|
| Shares Outstanding (Diluted) | 79 | 79 | 79 | 71 | 59 | Upgrade
|
| Shares Change (YoY) | 0.78% | 0.06% | 11.32% | 20.98% | - | Upgrade
|
| EPS (Basic) | 1.38 | 1.35 | 1.72 | 1.04 | 0.99 | Upgrade
|
| EPS (Diluted) | 1.38 | 1.35 | 1.71 | 1.02 | 0.98 | Upgrade
|
| EPS Growth | 2.22% | -21.05% | 67.14% | 3.91% | 63.09% | Upgrade
|
| Free Cash Flow | 27.86 | -10.29 | 104.6 | 32.48 | 37.11 | Upgrade
|
| Free Cash Flow Per Share | 0.35 | -0.13 | 1.33 | 0.46 | 0.63 | Upgrade
|
| Dividend Per Share | - | 0.250 | 0.180 | 0.083 | - | Upgrade
|
| Dividend Growth | - | 38.89% | 116.61% | - | - | Upgrade
|
| Gross Margin | 25.87% | 24.38% | 30.41% | 27.29% | 26.08% | Upgrade
|
| Operating Margin | 15.95% | 11.63% | 17.17% | 11.72% | 13.42% | Upgrade
|
| Profit Margin | 13.01% | 13.24% | 17.73% | 12.35% | 11.49% | Upgrade
|
| Free Cash Flow Margin | 3.31% | -1.28% | 13.76% | 5.54% | 7.38% | Upgrade
|
| EBITDA | 141.39 | 98.79 | 135.08 | 72.29 | 70.3 | Upgrade
|
| EBITDA Margin | 16.78% | 12.29% | 17.77% | 12.33% | 13.98% | Upgrade
|
| D&A For EBITDA | 7.05 | 5.35 | 4.55 | 3.56 | 2.81 | Upgrade
|
| EBIT | 134.34 | 93.44 | 130.52 | 68.73 | 67.49 | Upgrade
|
| EBIT Margin | 15.95% | 11.63% | 17.17% | 11.72% | 13.42% | Upgrade
|
| Effective Tax Rate | 14.26% | 12.46% | 16.33% | 10.42% | 13.62% | Upgrade
|
| Revenue as Reported | - | 803.73 | 760.04 | 586.23 | 502.97 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.